We Develop Innovative Healthcare Solutions Through Cannabis & Mushroom Based Sciences

About Psilosybin & Cannabinoids

Psilocybin – The Active Compound found in various mushrooms. FDA granted “breakthrough therapy” status to psilocybin in 2020. Acknowledgement that Major Depressive Disorder (MDD) represents an unmet medical need and suggests that psilocybin may offer a substantial clinical improvement over existing therapies.

Cannabinoids – The active compounds found in Cannabis. Cannabinoids are commonly used to treat seizure disorder, anxiety, pneumonia, dystonia, Parkinson disease, Crohn disease, and many other conditions.

Drug Target Discovery

Pre-Clinical Trials

Clinical Trials

FDA Approval

The potential for medicinal psychedelics &

cannabinoids have never been this big.

100$B

Estimated $100B USD global total addressable market for psychedelics.

97$B

“The global medical cannabis market size is projected to reach $97.35B USD by the end of 2026.”

42$B

Annual substance abuse treatment sales.

17.6$B

Annual anxiety, depression & ADHD drug sales.

Latest Press Releases

MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-11-15
MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-11-14
African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-11-03
M2MMA Announces 2024 Fight Schedule and Appoints CEO
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-10-12
M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-10-02
M2Bio Sciences Closes JDAX Acquisition
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-09-21
M2Bio Sciences Pharmacology & Clinical Application of CBD
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-09-15
M2bio Sciences Announces Launch of Exclusive MMA Organization
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-08-17
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-05-25
M2Bio Sciences to Showcase Latest in CBD Infused Foods and Beverages at the Plant Powered Show in Cape Town
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-05-23
M2Bio Appoints Ze-ev Krein as Chairman of the M2Bio Scientific Advisory Board
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-04-06
M2Bio Sciences Appoints Wilna Eksteen as M2Biome Senior Cardiometabolic Product Developer
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-04-05
M2Bio Sciences Exhibits at The Cape Town Cannabis Expo 2023
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-03-24
M2Bio Sciences Announces New Brand Ambassador: Shadrack “Blambee” Nsua
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-03-15
M2Bio Sciences announces Nicola Royce as M2Biome Managing Director
Source: EIN Presswire: Willem Jonker's Press Releases Published on 2023-03-14

Discover The Future

We are developing innovative healthcare solutions for humanity. We believe in improving the lives of all our consumers through solid scientific research.

We're glad you're here. Let's get to know each other.

Please have a look at the work we're doing. We'll love for you to be part of it.